Description

Orniliv Concentrate for Infusions 500 mg/ml. 10 ml. Vials №5

Ingredients:

Ornithine aspartate is the active ingredient in Orniliv concentrate for infusions.

Dosage:

The recommended dosage of Orniliv concentrate for infusions is determined by a healthcare professional based on the patient’s condition and needs.

Indications:

Orniliv concentrate for infusions is indicated for the treatment of hepatic encephalopathy and other liver-related conditions.

Contraindications:

Do not use Orniliv concentrate for infusions if you are allergic to any of the ingredients or have severe kidney problems.

Directions:

Orniliv concentrate for infusions is administered intravenously by a healthcare professional.

Scientific Evidence:

Orniliv has been studied in various clinical trials, showing significant improvement in hepatic encephalopathy symptoms compared to placebo.

Additional Information:

Orniliv concentrate for infusions is well-tolerated with minimal side effects reported in studies.

Pharmacological Effects:

Orniliv works by reducing ammonia levels in the blood, which helps improve brain function in patients with hepatic encephalopathy.

Clinical Trials:

In a double-blind, randomized controlled trial published in the Journal of Hepatology, Orniliv was found to be more effective than standard therapy in improving cognitive function in patients with hepatic encephalopathy.